Remove 2008 Remove Access Remove Data Remove Safety
article thumbnail

Johns Hopkins Receives $4M To Research Impacts of Psilocybin on Tobacco Addiction

Veriheal

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. In 2008, he published psychedelic safety guidelines.

article thumbnail

The Economic Impact of the Medical Marijuana Industry in Michigan

MMJ Recs

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Entrepreneurs and businesses leverage this data to navigate the competitive landscape, ensuring they meet market demands.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Study Says. Not One California Dispensary Caught Selling to Minors

Cannabis Law Report

was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ).

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D.,

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45